Rickey James Paul

CIK 00016062433 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001606243

Recent Transactions

50 trades

Purchase
Braveheart Bio, Inc.$BRVE
Common Stock
2026-08-07$18.00/sh+27,777→ 520,927 total
Award
Braveheart Bio, Inc.$BRVE
Stock Option (Right to Buy)
2026-08-05+300,000→ 300,000 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−78,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−108,999→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−26,761→ 31,200 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−31,200→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−836→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−137→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−143→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−112,945→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−1,214→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−112,500→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$13.20/sh+7,055→ 38,256 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$7.55/sh+1→ 31,201 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−398→ 137 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−18,286→ 1,214 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−164→ 836 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−857→ 143 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−7,055→ 112,945 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−1→ 108,999 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$5.02/sh+398→ 57,961 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$3.23/sh+18,286→ 57,563 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$11.31/sh+164→ 39,277 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$6.51/sh+857→ 39,113 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$25.00/sh−44,000→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-26−73,764→ 1,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-26−44,000→ 1,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$6.51/sh+73,764→ 73,764 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$22.31/sh−73,764→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$11.31/sh+44,000→ 44,000 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-25$22.00/sh−236→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-25−236→ 74,764 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-25$6.51/sh+236→ 236 total
Award
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-04+31,200→ 31,200 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-04+78,000→ 78,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-19−15,213→ 535 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$19.21/sh−15,213→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$5.02/sh+15,213→ 15,213 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-18$19.00/sh−1,800→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-18$5.02/sh+1,800→ 1,800 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-18−1,800→ 15,748 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-15$5.02/sh+45,387→ 45,387 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-15−45,387→ 17,548 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-15$19.09/sh−45,387→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-14−11,600→ 62,935 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-14$19.00/sh−11,600→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-14$5.02/sh+11,600→ 11,600 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-06$16.08/sh−6,446→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-06$3.23/sh+6,446→ 6,446 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-06−6,446→ 19,500 total

Companies

Recent Filings

Address

C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300

SAN FRANCISCO, CA, 94129

View on SEC.gov